BioRestorative Therapies, Inc. (BRTX)
USD 1.41
(-9.03%)
USD 1.41
(-9.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.43 Million | -5.87 Million | -3.32 Million | -1.96 Million | -6.91 Million | -5.1 Million |
| Net Income | -10.41 Million | -18.49 Million | -44.3 Million | -11.27 Million | -14.64 Million | -12.51 Million |
| Depreciation & Amortization | 165.73 Thousand | 120.54 Thousand | 89.1 Thousand | 121.38 Thousand | 217.35 Thousand | 240.37 Thousand |
| Deferred income taxes | -15.18 Thousand | - | 16.18 Million | 2.79 Million | 1.1 Million | 1.64 Million |
| Stock-based compensation | 7.78 Million | 12.61 Million | 23.1 Million | 691.7 Thousand | 1.65 Million | 2.39 Million |
| Change in working capital | 515.32 Thousand | 14.14 Thousand | 324.68 Thousand | 572.35 Thousand | 539.85 Thousand | -45.77 Thousand |
| Other non-cash items | 3.62 Million | -123.54 Thousand | 1.27 Million | 5.12 Million | 4.2 Million | 3.17 Million |
| Investing Cash Flow | 3.25 Million | -13.47 Million | -30.65 Thousand | - | -35.63 Thousand | -12.86 Thousand |
| Investments in PPE | -171.04 Thousand | -440.22 Thousand | -30.65 Thousand | - | -35.63 Thousand | -12.86 Thousand |
| Acquisitions | 171.04 Thousand | - | - | - | - | - |
| Investment purchases | -17.54 Million | -13.03 Million | - | - | - | - |
| Sales/Maturities of investments | 20.96 Million | 9.49 Million | - | - | - | - |
| Other Investing Activities | 3.42 Million | -13.13 Million | - | - | - | - |
| Financing Cash Flow | 2.34 Million | - | 21.32 Million | 5.02 Million | 6.83 Million | 4.78 Million |
| Debt repayment | - | - | -250 Thousand | -4.29 Million | -5.7 Million | -4.19 Million |
| Dividends payments | -569.06 Thousand | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.34 Million | - | 21.07 Million | 10 Thousand | 1.65 Million | 589.16 Thousand |
| Other Financing Activities | 2.35 Million | - | 500 Thousand | 736.9 Thousand | 10.88 Million | 589.16 Thousand |
| Accounts receivables | -3300.00 | -11 Thousand | 12 Thousand | 15 Thousand | -3000.00 | 9000.00 |
| Accounts payables | 18.48 Thousand | 120.07 Thousand | -68.02 Thousand | 84.63 Thousand | 97.09 Thousand | -516.11 Thousand |
| Inventory | -1.00 | - | - | - | 423.65 Thousand | 9.53 Million |
| Other working capital | 500.13 Thousand | -94.93 Thousand | 380.7 Thousand | 472.71 Thousand | 22.1 Thousand | -9.07 Million |
| Cash at beginning of period | 1.71 Million | 21.02 Million | 3.06 Million | 1664.00 | 117.52 Thousand | 451.68 Thousand |
| Cash at end of period | 884.37 Thousand | 1.67 Million | 21.02 Million | 3.06 Million | 1664.00 | 117.52 Thousand |
| Capital Expenditure | -171.04 Thousand | -440.22 Thousand | -30.65 Thousand | - | -35.63 Thousand | -12.86 Thousand |
| Effect of forex changes on cash | 34.62 Thousand | - | - | - | 1.00 | - |
| Net cash flow / Change in cash | -829.39 Thousand | -19.35 Million | 17.96 Million | 3.06 Million | -115.85 Thousand | -334.15 Thousand |
| Free Cash Flow | -6.6 Million | -6.31 Million | -3.36 Million | -1.96 Million | -6.95 Million | -5.11 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.02 Million | -2.22 Million | 1.17 Million | -10.41 Million | -2.92 Million | -2.98 Million |
| Depreciation & Amortization | 47.7 Thousand | 42.71 Thousand | 42.71 Thousand | 165.73 Thousand | 42.14 Thousand | 41.52 Thousand |
| Deferred income taxes | - | - | -1.56 Million | -15.18 Thousand | 40.99 Thousand | 11.01 Thousand |
| Stock-based compensation | 324.32 Thousand | 2.02 Million | 1.46 Million | 7.78 Million | 1.49 Million | 1.44 Million |
| Change in working capital | 192.98 Thousand | -475.69 Thousand | 129.06 Thousand | 515.32 Thousand | 141.92 Thousand | 283 Thousand |
| Other non-cash items | 2.02 Million | 398.07 Thousand | -3.01 Million | 3.62 Million | 29.01 Thousand | 29.01 Thousand |
| Investing Cash Flow | 2.97 Million | -4.92 Million | 100.66 Thousand | 3.25 Million | -23.05 Thousand | 665.8 Thousand |
| Investments in PPE | -35.29 Thousand | - | -70.02 Thousand | -171.04 Thousand | -11.94 Thousand | -29.04 Thousand |
| Acquisitions | - | - | -170.69 Thousand | 171.04 Thousand | 437.84 Thousand | - |
| Investment purchases | -2.05 Million | -10.72 Million | -17.1 Million | -17.54 Million | -437.84 Thousand | -6.06 Million |
| Sales/Maturities of investments | 5.06 Million | 5.8 Million | 17.27 Million | 20.96 Million | 426.73 Thousand | 694.85 Thousand |
| Other Investing Activities | 3 Million | - | 170.69 Thousand | 3.42 Million | -437.84 Thousand | 694.85 Thousand |
| Financing Cash Flow | -12.84 Thousand | 7.51 Million | 83.07 Thousand | 2.34 Million | 1.85 Million | 411.7 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -151.59 Thousand | -569.06 Thousand | -569.06 Thousand | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 7.52 Million | 83.07 Thousand | 2.34 Million | 1.85 Million | 411.7 Thousand |
| Other Financing Activities | -12.84 Thousand | -9538.00 | 85.64 Thousand | 2.35 Million | 1.85 Million | 411.7 Thousand |
| Accounts receivables | 7600.00 | -15.69 Thousand | 20 Thousand | -3300.00 | -14.3 Thousand | -9000.00 |
| Accounts payables | -14.98 Thousand | 41.51 Thousand | -37.96 Thousand | 18.48 Thousand | -48.69 Thousand | 183.46 Thousand |
| Inventory | - | - | - | -1.00 | - | - |
| Other working capital | 200.37 Thousand | -501.51 Thousand | 147.02 Thousand | 500.13 Thousand | 204.92 Thousand | 108.53 Thousand |
| Cash at beginning of period | 1.15 Million | 884.37 Thousand | 2.43 Million | 1.71 Million | 1.78 Million | 1.83 Million |
| Cash at end of period | 2.25 Million | 1.15 Million | 884.37 Thousand | 884.37 Thousand | 2.43 Million | 1.78 Million |
| Capital Expenditure | -35.29 Thousand | - | -70.02 Thousand | -171.04 Thousand | -11.94 Thousand | -29.04 Thousand |
| Effect of forex changes on cash | - | - | 34.62 Thousand | 34.62 Thousand | - | - |
| Net cash flow / Change in cash | 1.09 Million | 272.7 Thousand | -1.55 Million | -829.39 Thousand | 653.22 Thousand | -52.82 Thousand |
| Free Cash Flow | -1.9 Million | -2.31 Million | -1.84 Million | -6.6 Million | -1.18 Million | -1.15 Million |
WBTN
KURRF
VRSEF
TEPCY
688233
SNTI